Cited by 2,149Multiple Sclerosis Research StudiesT-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis

The DOI matches its Crossref record; 362 of the 362 references it cites were found in a registry or an index.

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Sospedra, Mireia, Martin, Roland·2005·Annual Review of Immunology

DOI 10.1146/annurev.immunol.23.021704.115707

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) develops in young adults with a complex predisposing genetic trait and probably requires an inciting environmental insult such as a viral infection to trigger the disease. The activation of CD4+ autoreactive T cells and their differentiation into a Th1 phenotype are a crucial events in the initial steps, and these cells are probably also important players in the long-term evolution of the disease. Damage of the target tissue, the central nervous system, is, however, most likely mediated by other components of the immune system, such as antibodies, complement, CD8+ T cells, and factors produced by innate immune cells. Perturbations in immunomodulatory networks that include Th2 cells, regulatory CD4+ T cells, NK cells, and others may in part be responsible for the relapsing-remitting or chronic progressive nature of the disease. However, an important paradigmatic shift in the study of MS has occurred in the past decade. It is now clear that MS is not just a disease of the immune system, but that factors contributed by the central nervous system are equally important and must be considered in the future.

Integrity signals

Registry

Crossref · 10.1146/annurev.immunol.23.021704.115707

Cites

362 of 362 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. M. (2003) · Science · doi:10.1126/science.1078231 · Cited by 2,000
Use of a cDNA microarray to analyse gene expression patterns in human cancer
DeRisi, J. L., Penland, L., Brown, P. O., Bittner, M. L., Meltzer, P. S., Ray, M., Chen, Y.-W., Su, Y. A., & Trent, J. M. (1996) · Nature Genetics · doi:10.1038/ng1296-457 · Cited by 1,952
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali‐Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J. E., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,918
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher‐Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,858
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M. N., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,683
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
Johnson, K., Brooks, B., Cohen, J. A., Ford, C., Goldstein, J., Lisak, R., Myers, L., Panitch, H., Rose, J., Schiffer, R., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,667

Show all 362 references

Research works printed but not linked: 12

McFarland HF, 1999, Am. J. Neuroradiol., 20, 1777
10.1172/JCI200421357 · DOI
Charcot J, 1868, Gaz. Hopitaux, 41, 554
Remlinger J, 1905, Ann. Inst. Pasteur, 19, 625
Berger T, 1997, Lab. Invest., 76, 355
10.1097/00019052-200306000-00004 · DOI
Sharief MK, 1991, Brain, 114, 181
Bornstein MB, 1959, Trans. Am. Neurol. Assoc., 84, 165
10.1002/1531-8249(200006)47:6<694::AID-ANA2>3.0.CO;2-W · DOI
Linington C, 1988, Am. J. Pathol., 130, 443
Benczur M, 1980, Clin. Exp. Immunol., 39, 657
10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-# · DOI

Sorted by citations

Items 501–600 of 1,006

Deletion of IL-33R (ST2) Abrogates Resistance to EAE in BALB/C Mice by Enhancing Polarization of APC to Inflammatory Phenotype
Milovanović, M., Volarević, V., Ljujić, B., Radosavljevic, G. D., Jovanović, I., Arsenijević, N., & Lukić, M. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045225 · Cited by 68
Identification of novel mimicry epitopes for cardiac myosin heavy chain-α that induce autoimmune myocarditis in A/J mice
Massilamany, C., Gangaplara, A., Steffen, D. J., & Reddy, J. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.08.013 · Cited by 70
Simvastatin Inhibits IFN Regulatory Factor 4 Expression and Th17 Cell Differentiation in CD4+ T Cells Derived from Patients with Multiple Sclerosis
Zhang, X., Tao, Y., Troiani, L., & Markovic‐Plese, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100580 · Cited by 68
Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond neuroprotection
Laroni, A., de Rosbo, N. K., & Uccelli, A. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.08.007 · Cited by 67
STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE
McWilliams, I. L., Rajbhandari, R., Nozell, S. E., Benveniste, E. N., & Harrington, L. E. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0351-3 · Cited by 73
Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors
Urich, E., Gutcher, I., Prinz, M., & Becher, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607283103 · Cited by 67
Influence of the HLA-DRB1 Genotype on Antibody Development to Interferon Beta in Multiple Sclerosis
Buck, D., Cepok, S., Hoffman, S., Grummel, V., Jochim, A., Berthele, A., Hartung, H., Waßmuth, R., & Hemmer, B. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.65 · Cited by 67
Naturally Presented Peptides on Major Histocompatibility Complex I and II Molecules Eluted from Central Nervous System of Multiple Sclerosis Patients
Fissolo, N., Haag, S., de Graaf, K. L., Drews, O., Stevanović, S., Rammensee, H. G., & Weissert, R. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900001-mcp200 · Cited by 67
Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?
Adamczyk-Sowa, M. H., Medrek, A., Madej, P., Michlicka, W., & Dobrakowski, P. P. (2017) · Journal of Immunology Research · doi:10.1155/2017/7904821 · Cited by 68
MiR-126 and miR-126* regulate shear-resistant firm leukocyte adhesion to human brain endothelium
Cerutti, C., Edwards, L. J., de Vries, H. E., Sharrack, B., Male, D. K., & Romero, I. A. (2017) · Scientific Reports · doi:10.1038/srep45284 · Cited by 67
Heat Shock Protein 70: Roles in Multiple Sclerosis
Mansilla, M. J., Montalbán, X., & Espejo, C. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00119 · Cited by 70
Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?
Boorman, E., Zajkowska, Z., Ahmed, R., Pariante, C. M., & Zunszain, P. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4105-9 · Cited by 68
Multiple sclerosis – a response-to-damage model
Hart, B. A. ‘., Hintzen, R. Q., & Laman, J. D. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.04.001 · Cited by 66
PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices
Kim, J., Byun, J.-W., Choi, I., Kim, B., Jeong, H., Jou, I., & Joe, E.-H. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.1.38 · Cited by 71
Gut dysbiosis and multiple sclerosis
Noto, D., & Miyake, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108380 · Cited by 65
Fast Progression of Recombinant Human Myelin/Oligodendrocyte Glycoprotein (MOG)-Induced Experimental Autoimmune Encephalomyelitis in Marmosets Is Associated with the Activation of MOG34–56-Specific Cytotoxic T Cells
Kap, Y. S., Smith, P., Jagessar, S. A., Remarque, E. J., Blezer, E. L. A., Strijkers, G. J., Laman, J. D., Hintzen, R. Q., Bauer, J., Brok, H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1326 · Cited by 65
Paranodal myelin retraction in relapsing experimental autoimmune encephalomyelitis visualized by coherent anti-Stokes Raman scattering microscopy
Fu, Y., Cheng, J., Frederick, T. J., Goings, G. E., Miller, S. D., & Huff, T. B. (2011) · Journal of Biomedical Optics · doi:10.1117/1.3638180 · Cited by 67
An Imbalance of Two Functionally and Phenotypically Different Subsets of Plasmacytoid Dendritic Cells Characterizes the Dysfunctional Immune Regulation in Multiple Sclerosis
Schwab, N., Zozulya, A. L., Kieseier, B. C., Toyka, K. V., & Wiendl, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903662 · Cited by 65
Estrogen protection against EAE modulates the microbiota and mucosal-associated regulatory cells
Benedek, G., Zhang, J., Nguyen, H., Kent, G., Seifert, H. A., Davin, S., Stauffer, P., Vandenbark, A. A., Karstens, L., Asquith, M., et al. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.06.007 · Cited by 64
CSF levels of YKL-40 are increased in MS and decrease with immunosuppressive treatment
Malmeström, C., Axelsson, M., Lycke, J., Zetterberg, H., Blennow, K., & Olsson, B. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.02.004 · Cited by 64
Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response
Adzemovic, M. Z., Zeitelhofer, M., Eriksson, U., Olsson, T. P., & Nilsson, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056586 · Cited by 66
Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis
Pittet, C. L., Newcombe, J., Prat, A., & Arbour, N. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-155 · Cited by 67
Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models
Mars, L. T., Saikali, P., Liblau, R., & Arbour, N. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.006 · Cited by 70
PROTECTING THE PUMP: Controlling Myocardial Inflammatory Responses
Taqueti, V. R., Mitchell, R. N., & Lichtman, A. H. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.040104.124611 · Cited by 64
A phase 2, 24-week, randomized, placebo-controlled, double-blind study examining the efficacy and safety of an anti-interleukin-12 and -23 monoclonal antibody in patients with relapsing–remitting or secondary progressive multiple sclerosis
Vollmer, T. L., Wynn, D. R., Alam, M. S., & Valdes, J. M. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510384496 · Cited by 65
Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis
Makar, T. K., Gerzanich, V., Nimmagadda, V. K. C., Jain, R., Lam, K., Mubariz, F., Trisler, D. N., Ivanova, S., Woo, S. K., Kwon, M. S., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0432-3 · Cited by 64
Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis
Nogueras, L., Gonzalo‐Benito, H., Jové, M., Sol, J., Gil-Sánchez, A., Hervás, J. V., Valcheva, P., González‐Mingot, C., Solana, M. J., Peralta, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47906-x · Cited by 63
Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression
Sundaram, G., Lim, C. K., Brew, B. J., & Guillemin, G. J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01844-y · Cited by 64
Disease-Modifying Agents for Multiple Sclerosis
Menge, T., Weber, M. S., Hemmer, B., Kieseier, B. C., von Büdingen, H. ‐., Warnke, C., Zamvil, S. S., Boster, A. L., Khan, O., Hartung, H. P., et al. (2008) · Drugs · doi:10.2165/0003495-200868170-00004 · Cited by 66
A Potential Role for B-Cell Activating Factor in the Pathogenesis of Autoimmune Myasthenia Gravis
Ragheb, S., Lisak, R. P., Lewis, R. A., Stavern, G. P. V., Gonzales, F., & Simon, K. W. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1358 · Cited by 64
Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitis
Benedek, G., Zhang, J., Bodhankar, S., Nguyen, H., Kent, G., Jordan, K. R., Manning, D., Vandenbark, A. A., & Offner, H. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.02.009 · Cited by 63
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier
Zeitelhofer, M., Adzemovic, M. Z., Moessinger, C., Stefanitsch, C., Strell, C., Muhl, L., Brundin, L., Fredriksson, L., Olsson, T. P., Eriksson, U., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-79598-z · Cited by 63
Early Life Exposure to Lipopolysaccharide Suppresses Experimental Autoimmune Encephalomyelitis by Promoting Tolerogenic Dendritic Cells and Regulatory T Cells
Ellestad, K. K., Tsutsui, S., Noorbakhsh, F., Warren, K. G., Yong, V. W., Pittman, Q. J., & Power, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803576 · Cited by 63
Collagenase-2 Deficiency or Inhibition Impairs Experimental Autoimmune Encephalomyelitis in Mice
Folgueras, A. R., Fueyo, A., García‐Suárez, O., Cox, J. H., Astudillo, A., Tortorella, P., Campestre, C., Gutiérrez‐Fernández, A., Fanjul‐Fernández, M., Pennington, C. J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709522200 · Cited by 63
Modulation of inflammatory pathways by the immune cholinergic system
Nizri‏, E., & Brenner, T. (2011) · Amino Acids · doi:10.1007/s00726-011-1192-8 · Cited by 65
Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis
Schwab, N., Schneider‐Hohendorf, T., & Wiendl, H. (2014) · International Immunology · doi:10.1093/intimm/dxu096 · Cited by 65
A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica
Gebregiworgis, T., Nielsen, H. H., Massilamany, C., Gangaplara, A., Reddy, J., Illés, Z., & Powers, R. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b01111 · Cited by 63
Kinin receptors: Key regulators of autoimmunity
Dutra, R. C. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.12.011 · Cited by 66
Comparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycin
Navarro‐Barriuso, J., Mansilla, M. J., Naranjo‐Gómez, M., Sánchez‐Pla, Á., Quirant‐Sánchez, B., Teniente‐Serra, A., Ramo-Tello, C. M., & Martínez-Cáceres, E. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-33248-7 · Cited by 63
Multiple Sclerosis disease distribution and potential impact of environmental air pollutants in Georgia
Gregory, A. C., Shendell, D. G., Okosun, I. S., & Gieseker, K. E. (2008) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2008.01.065 · Cited by 62
IL-11 Induces Th17 Cell Responses in Patients with Early Relapsing-Remitting Multiple Sclerosis
Zhang, X., Tao, Y., Chopra, M., Dujmović, I., Jin, J., Tang, Y., Drulovic, J. S., & Markovic‐Plese, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401680 · Cited by 62
MeCP2 Reinforces STAT3 Signaling and the Generation of Effector CD4 + T Cells by Promoting miR-124–Mediated Suppression of SOCS5
Jiang, S., Li, C., McRae, G., Lykken, E. A., Sevilla, J., Liu, S.-Q., Wan, Y., & Li, Q.-J. (2014) · Science Signaling · doi:10.1126/scisignal.2004824 · Cited by 63
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation
Hoffmann, O. M., Zipp, F., & Weber, J. R. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0484-x · Cited by 62
Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood
Yadav, S. K., Boppana, S., Ito, N., Mindur, J. E., Mathay, M., Patel, A. H., Dhib-Jalbut, S. S., & Ito, K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615715114 · Cited by 62
Western lifestyle and immunopathology of multiple sclerosis
Matveeva, O., Bogie, J. F. J., Hendriks, J. J. A., Linker, R. A., Haghikia, A., & Kleinewietfeld, M. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13583 · Cited by 65
Immunometabolism and autoimmunity
Freitag, J., Berod, L., Kamradt, T., & Sparwasser, T. D. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.77 · Cited by 61
Multiple sclerosis: an infectious syndrome involving Chlamydophila pneumoniae
Stratton, C. W., & Wheldon, D. B. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.09.002 · Cited by 60
Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients
Calabrese, M., Reynolds, R., Magliozzi, R., Castellaro, M., Morra, A., Scalfari, A., Farina, G., Romualdi, C., Gajofatto, A., Pitteri, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135428 · Cited by 60
Metabolic defects in multiple sclerosis
Adiele, R. C., & Adiele, C. A. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.12.005 · Cited by 62
Thymic involution and proliferative T-cell responses in multiple sclerosis
Duszczyszyn, D. A., Williams, J. L., Mason, H., Lapierre, Y., Antel, J. P., & Haegert, D. G. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.02.005 · Cited by 61
The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: Evidence for the involvement of astrocytes
Dutra, R. C., Bento, A. F., Leite, D. F. P., Manjavachi, M. N., Marcon, R., Bicca, M. A., Pesquero, J. B., & Calixto, J. Β. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.02.007 · Cited by 60
Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation
Bogie, J. F. J., Stinissen, P., Hellings, N., & Hendriks, J. J. A. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-85 · Cited by 62
Infection Risk in Patients on Multiple Sclerosis Therapeutics
Williamson, E. M. L., & Berger, J. R. (2015) · CNS Drugs · doi:10.1007/s40263-015-0226-2 · Cited by 60
Neuroendocrine Immunoregulation in Multiple Sclerosis
Deckx, N., Lee, W.-P., Berneman, Z. N., & Cools, N. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/705232 · Cited by 62
Azathioprine for multiple sclerosis
Casetta, I., Iuliano, G., & Filippini, G. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.144972 · Cited by 59
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance
Hundeshagen, A., Hecker, M., Paap, B. K., Angerstein, C., Kandulski, O., Fatum, C., Hartmann, C., Koczan, D., Thiesen, H., & Zettl, U. K. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-140 · Cited by 61
Treatment of multiple sclerosis: current concepts and future perspectives
Buck, D., & Hemmer, B. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6101-2 · Cited by 59
Mdivi-1, a mitochondrial fission inhibitor, modulates T helper cells and suppresses the development of experimental autoimmune encephalomyelitis
Lǐ, Y., Xu, F., Thomé, R., Guo, M., Sun, M., Song, G., Li, R.-L., Chai, Z., Ćirić, B., Rostami, A. M., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1542-0 · Cited by 58
Neuroprotective role of fibroblast growth factor‐2 in experimental autoimmune encephalomyelitis
Rottlaender, A., Villwock, H., Addicks, K., & Küerten, S. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03450.x · Cited by 58
Sphingolipids: Important Players in Multiple Sclerosis
Halmer, R., Walter, S., & Fassbender, K. C. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000362988 · Cited by 58
Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis
Santi, L. D., Annunziata, P., Sessa, E., & Bramanti, P. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.057 · Cited by 58
Effects of exercise training on cytokines and adipokines in multiple Sclerosis: A systematic review
Negaresh, R., Motl, R. W., Mokhtarzade, M., Dalgas, U., Patel, D. I., Shamsi, M. M., Majdinasab, N., Ranjbar, R., Zimmer, P., & Baker, J. S. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.06.008 · Cited by 58
Exploring the Use of Dimethyl Fumarate as Microglia Modulator for Neurodegenerative Diseases Treatment
Rosito, M., Testi, C., Parisi, G., Cortese, B., Baiocco, P., & Angelantonio, S. D. (2020) · Antioxidants · doi:10.3390/antiox9080700 · Cited by 61
A Network Analysis of the Human T-Cell Activation Gene Network Identifies Jagged1 as a Therapeutic Target for Autoimmune Diseases
Palacios, R., Goñi, J., Martínez‐Forero, I., Iranzo, J., Sepulcre, J., Melero, I., & Villoslada, P. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001222 · Cited by 58
Microarray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early IFNβ-responsive genes in peripheral blood lymphocytes in vitro: an implication for IFNβ-related adverse effects in multiple sclerosis
Satoh, J., Nanri, Y., Tabunoki, H., & Yamamura, T. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-18 · Cited by 58
Single-nucleotide polymorphisms in HLA- and non-HLA genes associated with the development of antibodies to interferon-β therapy in multiple sclerosis patients
Weber, F., Cepok, S., Wolf, C., Berthele, A., Uhr, M., Bettecken, T., Buck, D., Hartung, H., Holsboer, F., Müller‐Myhsok, B., et al. (2011) · The Pharmacogenomics Journal · doi:10.1038/tpj.2011.14 · Cited by 57
Mitochondria, Oxidative Stress, cAMP Signalling and Apoptosis: A Crossroads in Lymphocytes of Multiple Sclerosis, a Possible Role of Nutraceutics
Signorile, A., Ferretta, A., Ruggieri, M., Paolicelli, D., Lattanzio, P., Trojano, M., & Rasmo, D. D. (2020) · Antioxidants · doi:10.3390/antiox10010021 · Cited by 62
Skin and gut imprinted helper T cell subsets exhibit distinct functional phenotypes in central nervous system autoimmunity
Hiltensperger, M., Beltrán, E., Kant, R., Tyystjärvi, S., Lepennetier, G., Moreno, H. D., Bauer, I., Grassmann, S. A., Jarosch, S., Schober, K., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00948-8 · Cited by 65
Increased T-cell immunity against aquaporin-4 and proteolipid protein in neuromyelitis optica
Matsuya, N., Komori, M., Nomura, K., Nakane, S., Fukudome, T., Goto, H., Shiraishi, H., Wandinger, K.-P., Matsuo, H., & Kondo, T. (2011) · International Immunology · doi:10.1093/intimm/dxr056 · Cited by 57
Internalization and presentation of myelin antigens by the brain endothelium guides antigen-specific T cell migration
Pinheiro, M. A. L., Kamermans, A., García-Vallejo, J. J., Hof, B. V. H., Wierts, L., O’Toole, T. G., Boeve, D., Verstege, M. I., van der Pol, S. M. A., van Kooyk, Y., et al. (2016) · eLife · doi:10.7554/elife.13149 · Cited by 59
The role of TRAIL/TRAIL receptors in central nervous system pathology
Aktaş, O. (2007) · Frontiers in bioscience · doi:10.2741/2281 · Cited by 57
B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms
Podojil, J. R., Liu, L. N., Marshall, S. A., Chiang, M.-Y., Goings, G. E., Chen, L., Langermann, S., & Miller, S. D. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.04.001 · Cited by 56
Interferon-β is a key regulator of proinflammatory events in experimental autoimmune encephalomyelitis
Galligan, C. L., Pennell, L. M., Murooka, T. T., Baig, E. R., Majchrzak-Kita, B., Rahbar, R., & Fish, E. R. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510381259 · Cited by 56
Pathophysiology of translational regulation by microRNAs in multiple sclerosis
Junker, A. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.052 · Cited by 56
Is there a link between inflammation and fatigue in multiple sclerosis?
Chalah, M. A., & Ayache, S. S. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s167199 · Cited by 56
Multiple Sclerosis: New Aspects of Immunopathogenesis
Lazibat, I. (2018) · Acta Clinica Croatica · doi:10.20471/acc.2018.57.02.17 · Cited by 56
The majority of infiltrating CD8 T lymphocytes in multiple sclerosis lesions is insensitive to enhanced PD‐L1 levels on CNS cells
Pittet, C. L., Newcombe, J., Antel, J. P., & Arbour, N. (2011) · Glia · doi:10.1002/glia.21158 · Cited by 56
CD4+ memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis
Krakauer, M., Sørensen, P. S., & Sellebjerg, F. T. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.09.006 · Cited by 56
The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis
Angelini, G., Bani, A., Constantin, G., & Rossi, B. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1101379 · Cited by 57
Interleukin-33 is released in spinal cord and suppresses experimental autoimmune encephalomyelitis in mice
Chen, H.-Z., Sun, Y. T., Lai, L., Wu, H., Xiao, Y., Ming, B., Gao, M., Zou, H., Xiong, P., Xu, Y., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.019 · Cited by 55
Shifting imaging targets in multiple sclerosis: From inflammation to neurodegeneration
Vigeveno, R. M., Wiebenga, O. T., Wattjes, M. P., Geurts, J. J. G., & Barkhof, F. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23578 · Cited by 56
Evidence for early, non-lesional cerebellar damage in patients with multiple sclerosis: DTI measures correlate with disability, atrophy, and disease duration
Deppe, M., Tabelow, K., Krämer, J., Tenberge, J., Schiffler, P., Bittner, S., Schwindt, W., Zipp, F., Wiendl, H., & Meuth, S. G. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515579439 · Cited by 55
G protein-coupled receptors as therapeutic targets for multiple sclerosis
Du, C., & Xie, X. (2012) · Cell Research · doi:10.1038/cr.2012.87 · Cited by 56
Serum Adiponectin, TNF-α, IL-12p70, and IL-13 Levels in Multiple Sclerosis and the Effects of Different Therapy Regimens
Muşabak, U., Demirkaya, Ş., Genç, G., Sağkan, R. I., & Odabaşı, Z. (2010) · NeuroImmunoModulation · doi:10.1159/000317393 · Cited by 55
Anti‐inflammatory effects of melatonin in multiple sclerosis
Farez, M., Calandri, I. L., Correale, J. D., & Quintana, F. J. (2016) · BioEssays · doi:10.1002/bies.201600018 · Cited by 55
B cells in multiple sclerosis
Sospedra, M. (2018) · Current Opinion in Neurology · doi:10.1097/wco.000000000000563 · Cited by 57
Self-citation
Air pollution as a contributor to the inflammatory activity of multiple sclerosis
Cortese, A., Lova, L., Comoli, P., Volpe, E., Villa, S., Mallucci, G., Salvia, S. L., Romani, A., Franciotta, D. M., Bollati, V., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01977-0 · Cited by 58
Amino Acid Solute Carrier Transporters in Inflammation and Autoimmunity
Sheng, L., Luo, Q., & Chen, L. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000705 · Cited by 56
Molecular “Negativity” May Underlie Multiple Sclerosis: Role of the Myelin Basic Protein Family in the Pathogenesis of MS
Musse, A. A., & Harauz, G. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)79007-4 · Cited by 54
Expression of IL ‐33 and its epigenetic regulation in multiple sclerosis
Zhang, F., Tossberg, J. T., Spurlock, C. F., Yao, S., Aune, T. M., & Sriram, S. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.47 · Cited by 54
Recognition Pliability Is Coupled to Structural Heterogeneity: A Calmodulin Intrinsically Disordered Binding Region Complex
Nagulapalli, M., Parigi, G., Yuan, J., Gsponer, J., Deraos, G., Bamm, V. V., Harauz, G., Matsoukas, J., de Planque, M. R. R., Gerothanassis, I. P., et al. (2012) · Structure · doi:10.1016/j.str.2012.01.021 · Cited by 54
Towards Clinical Application of Mesenchymal Stem Cells for Treatment of Neurological Diseases of the Central Nervous System
Laroni, A., Novi, G., de Rosbo, N. K., & Uccelli, A. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9456-6 · Cited by 54
Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis
Villar, L. M., Picón, C., Costa‐Frossard, L., Alenda, R., García‐Caldentey, J., Espiño, M., Muriel, A., & Álvarez‐Cermeño, J. C. (2014) · European Journal of Neurology · doi:10.1111/ene.12579 · Cited by 54
Differential Expression of CD11c by Peripheral Blood NK Cells Reflects Temporal Activity of Multiple Sclerosis
Aranami, T., Miyake, S., & Yamamura, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5659 · Cited by 54
Intermittent feeding attenuates clinical course of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Kafami, L., Raza, M., Razavi, A., Mirshafiey, A., Movahedian, M., & Khorramizadeh, M. R. (2010) · Europe PMC (PubMed Central) · Cited by 54
PPARα as a therapeutic target in inflammation-associated diseases
Gervois, P. P., & Mansouri, R. M. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.715633 · Cited by 54
Signaling via toll-like receptor 4 and CD40 in B cells plays a regulatory role in the pathogenesis of multiple sclerosis through interleukin-10 production
Okada, Y., Ochi, H., Fujii, C., Hashi, Y., Hamatani, M., Ashida, S., Kawamura, K., Kusaka, H., Matsumoto, S., Nakagawa, M., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.10.011 · Cited by 54
Social cognition deficits and the role of amygdala in relapsing remitting multiple sclerosis patients without cognitive impairment
Pitteri, M., Genova, H. M., Lengenfelder, J., DeLuca, J., Ziccardi, S., Rossi, V., & Calabrese, M. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.01.030 · Cited by 54
The role of B cells in the immunopathogenesis of multiple sclerosis
Gharibi, T., Babaloo, Z., Hosseini, A., Marofi, F., Kalan, A. E., Jahandideh, S., & Baradaran, B. (2020) · Immunology · doi:10.1111/imm.13198 · Cited by 58
Immunosuppressive Amino-Acid Catabolizing Enzymes in Multiple Sclerosis
Correale, J. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.600428 · Cited by 54

Authors: Sospedra, M., & Martin, R.
Affiliations: National Institutes of Health (US)
Cellular Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400;
ORCID: Sospedra, Mireia
Venue: Annual Review of Immunology
Publisher: Annual Reviews
Published: 2005-04-01
Volume: 23
Issue: 1
Pages: 683-747
ISSN: 0732-0582 (ISSN-L)
1545-3278
DOI: 10.1146/annurev.immunol.23.021704.115707
OpenAlex: W2113291839
Cited by: 2,149
References: 362
Citations by year: 2026: 27 · 2025: 43 · 2024: 62 · 2023: 64 · 2022: 69 · 2021: 72 · 2020: 78 · 2019: 84 · 2018: 71 · 2017: 110 · 2016: 107 · 2015: 149 · 2014: 133 · 2013: 144 · 2012: 120
FWCI: 19.06
Type: journal article
Language: en
Open access: closed
Locations: Annual Review of Immunology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords: multiple sclerosis, autoimmunity, CD4+ T cells, Th1 cells, Th2 cells, regulatory T cells, natural killer cells, CD8+ T cells, complement system, autoantibodies, innate immunity, viral triggers, genetic susceptibility, relapsing-remitting disease, chronic progressive disease, central nervous system, neuroimmune interactions
MeSH terms: Autoantibodies, Autoantigens, Central Nervous System, HLA Antigens, Humans, Immunity, Innate, Immunogenetics, Infections, Multiple Sclerosis, Myelin Proteins, T-Lymphocyte Subsets, Cytokines, Models, Immunological, Molecular Mimicry, Chemokines, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks